[ad_1]
Hong Kong scientists announced on Monday that an affordable antimicrobial drug used to treat stomach ulcers and bacterial infections has shown promising results in fighting the Corona virus in animals.
The researchers worked to explore whether mineral drugs, compounds that contain minerals and are commonly used to fight bacteria, may also have antiviral properties that can fight the SARS-Covid-2 virus.
Using Syrian mice in the lab, the researchers found that one of the drugs, ranitidine bismuth citrate, was a “strong anti-SARS-Cove-2 agent.”
University of Hong Kong researcher Ranming Wang told reporters on Monday as the team presented the study that ranitidine bismuth citrate “is capable of reducing the viral load in the lung of an infected mouse tenfold. .. Our findings show that this drug is a potential antiviral agent. ” In the case of COVID-19 “.
The new Corona virus has killed more than a million people since its appearance in China last December, before spreading across the world.
As scientists scramble to find an effective vaccine, they are also looking for readily available drugs that can ease symptoms caused by Covid-19 disease or help the body fight infections.
Both remdesivir, a broad-spectrum antiviral drug, and dexamethasone, a type of corticosteroid, were found to have some success against the virus.
Doctors used both drugs to treat US President Donald Trump after contracting Covid-19.
However, remdesivir is expensive and there is a global shortage of stocks. Dexamethasone has immunosuppressive effects that are risky for all but the sickest patients.
alreadyLoaded_facebookConnect = false;
$(window).load(function () {
//$(window).bind('mousemove' , function(){ // $(window).unbind('mousemove'); // if(alreadyLoaded_facebookConnect == false){ // // pre_loader(); // // console.log("test"); // } //});
if ($(window).scrollTop() != 0 && alreadyLoaded_facebookConnect == false) {
alreadyLoaded_facebookConnect = true; (function (d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk')); // pre_loader(); // $(window).unbind('mousemove'); // console.log(" loaded"); //setTimeout(function(){ // $('#boxTwitter').html("Tweets by @tayyar_org"); //}, 3000);}}); //$(window).bind('scroll '); $ (window) .scroll (function () {if (alreadyLoaded_facebookConnect == false) {alreadyLoaded_facebookConnect = true ; // $ (window) .unbind ('scroll'); // console.log ("scroll loaded"); (function (d, s, id) {var js, fjs = d.getElementsByTagName (s)[0]; if (d.getElementById (id)) return; js = d.createElement (s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore (js, fjs); } (document, 'script', 'facebook-jssdk')); // pre_loader (); // $ (window) .unbind ('mousemove'); // setTimeout (function () {// $ ('# boxTwitter'). html ("Tweets from @tayyar_org"); //}, 3000); var scriptTag = document.createElement (" script "); scriptTag.type =" text / javascript "scriptTag.src =" https://news.google.com/scripts/social. js "; scriptTag.async = true; document.getElementsByTagName (" head ")[0].appendChild (scriptTag); (function () {$ .getScript ("https://news.google.com/scripts/social.js", function () {});}); }}); //$(window).load(function () {// setTimeout (function () {// // add the returned content to a newly created script tag // var se = document.createElement ('script'); / / se.type = "text / javascript"; // //se.async = true; // se.text = "setTimeout (function () {pre_loader ();}, 5000);"; // document. getElementsByTagName ('body')[0].appendChild (se); //}, 5000); //});
[ad_2]